We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Rachael G. Pontikes Duane Morris LLP

Results 1 to 5 of 6



Congress drafts compounding legislation -- defines compounded drugs as new drugs under the FFDCA and creates bright line between traditional compounders and compounding manufacturers *

USA - April 29 2013
In the wake of the New England Compounding Center meningitis outbreak, the federal government has actively pushed for greater legislative oversight…

Co-authors: Elinor L. Hart.


Compounding animal drugs from bulk ingredients *

USA - April 17 2013
Recent public discussion about the federal role in regulating compounding pharmacies has focused on compounded drugs for human use. Compounded…

Co-authors: Elinor L. Hart.


FDA emphasizes patient-specific prescriptions *

USA - March 21 2013
On March 7, 2013, the United States Food and Drug Administration (FDA) issued a warning letter to compounding pharmacy Medi-Fare Drug & Home Health…

Co-authors: Elinor L. Hart.


FDA tightens requirement for patient-specific prescriptions in the wake of the meningitis outbreak *

USA - February 25 2013
In a letter to compounding pharmacy PharMEDium, the U.S. Food and Drug Administration (FDA) stated it was no longer willing to accept an alternate…


U.S. government's use of the Park Doctrine to police pharmacies *

USA - January 7 2013
The U.S. government may be resurrecting the "Park Doctrine" as a tool to prosecute the owners of pharmacies for federal Food, Drug, and Cosmetic Act…

Co-authors: Frederick R. Ball.


Next »